JOSEPHA SIMI: Open Payments
NPI 1861893729 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,904 in 199 payments from 19 companies in 2025. Trend: 2023 $2,619 · 2024 $4,360 · 2025 $3,904
Food & beverage: $3,904
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 81 | $1,714 |
| PFIZER INC. | 51 | $617 |
| Lundbeck LLC | 11 | $257 |
| Teva Pharmaceuticals USA, Inc. | 16 | $242 |
| Biogen, Inc. | 11 | $236 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Novo Nordisk Inc | 1 | $119 |
| Neurocrine BioSciences, Inc. | 3 | $96 |
| Merz Pharmaceuticals, LLC | 4 | $87 |
| Alexion Pharmaceuticals, Inc. | 2 | $64 |
Products named: BOTOX, QULIPTA, NURTEC ODT, UBRELVY, VYEPTI, TYSABRI, AUSTEDO XR, ZAVZPRET.
Industry payments across CA — which companies pay providers there.
